Results 11 to 20 of about 61,853 (265)
Introduction Secondary tumoral parkinsonism is a rare phenomenon that develops as a direct or indirect result of brain neoplasms or related conditions.
Gustav Cedergren Weber +4 more
doaj +1 more source
Tyrosine kinase inhibitors (TKIs) are effective therapies for leukaemia. Alzheimer is a neurodegenerative disease characterized by accumulation of β‐amyloid (plaques) and hyper‐phosphorylated Tau (tangles).
Irina Lonskaya +4 more
doaj +1 more source
New Perspective on Parkinsonism in Frontotemporal Lobar Degeneration [PDF]
Frontotemporal dementia (FTD) is the second most common type of presenile dementia. Three clinical prototypes have been defined; behavioral variant FTD, semantic dementia, and progressive nonfluent aphasia.
Hee Kyung Park, Sun J. Chung
doaj +1 more source
X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B
X-linked Dystonia-Parkinsonism (XDP) is a progressive neurodegenerative disease involving the loss of medium spiny neurons within the striatum. An XDP-specific haplotype has been identified, consisting of seven sequence variants which cluster around the ...
Christine A. Vaine +7 more
doaj +1 more source
Altered resting state brain metabolic connectivity in dementia with Lewy bodies
Although dementia with Lewy bodies (DLB) have Parkinsonism in common with Parkinson's disease (PD) or PD dementia (PDD), they have different neuropathologies that underlie Parkinsonism.
Euna Choi +11 more
doaj +1 more source
The Current State of Parkinsonism in West Africa: A Systematic Review
Parkinsonism is one of the most common neurodegenerative diseases among the elderly. Africa is experiencing an increasing burden of age-related conditions including parkinsonism.
Jude T. Quarshie +3 more
doaj +1 more source
Parkinson’s Disease and Parkinsonism
Parkinson’s disease (PD), or paralysis agitans is a common neurodegenerative and heterogeneous disorder. Parkinson’s symptoms include bradykinesia, rigidity and tremor. PD is pathologically characterized by the loss of dopaminergic neurons of the substantia nigra. Treatment involves pharmacologic and nonpharmacologic approaches.
Tuba Erdoğan Soyukibar, Dilaver Kaya
openaire +1 more source
Burden of Parkinsonism and Parkinson’s Disease on Health Service Use and Outcomes in Latin America
Background: Little is known about the burden of parkinsonism and Parkinson’s disease (PD) in Latin America. Better understanding of health service use and clinical outcomes in PD is needed to improve its prognosis.
Dani J. Kim +14 more
doaj +1 more source
Study on drug-induced parkinsonism and its clinical patterns in Eastern Indian population
Background: Drug-induced parkinsonism (DIP) is important as it is reversible if identified and treated early. We present herewith various clinical patterns and drugs commonly causing DIP.
Praveen Kumar Yadav
doaj +1 more source
Parkinson's Disease and Parkinsonism: Neuropathology [PDF]
Parkinsonism, the clinical term for a disorder with prominent bradykinesia and variable associated extrapyramidal signs and symptoms, is accompanied by degeneration of the nigrostriatal dopaminergic system, with neuronal loss and reactive gliosis in the substantia nigra found at autopsy.
openaire +2 more sources

